Previous close | 91.90 |
Open | 91.83 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 91.09 - 92.24 |
52-week range | 80.60 - 104.32 |
Volume | |
Avg. volume | 1,382,514 |
Market cap | 114.712B |
Beta (5Y monthly) | 0.45 |
PE ratio (TTM) | 25.43 |
EPS (TTM) | 3.59 |
Earnings date | 25 Jul 2024 |
Forward dividend & yield | 3.76 (4.09%) |
Ex-dividend date | 13 May 2024 |
1y target est | 106.50 |
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2024 Earnings Call Transcript May 2, 2024 Regeneron Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $9.55 EPS, expectations were $10.17. Regeneron Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to […]
Q1 2024 Kymera Therapeutics Inc Earnings Call
Regeneron (REGN) reports Q1 results, wherein both the top and bottom lines miss estimates due to lower Eylea sales. Shares down.